EVEROLIMUS 2.5 mg/1
everolimus · TABLET · NorthStar RxLLC
No Recall HistoryCurrently in Shortage
Plain English
EVEROLIMUS is a tablet containing everolimus at 2.5 mg/1, taken oral. Manufactured by NorthStar RxLLC.
Key Facts
- Brand Name
- EVEROLIMUS
- Generic Name
- everolimus
- NDC Code (Product)
72603-254- Manufacturer
- NorthStar RxLLC
- Strength
- 2.5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA214182
- Drug Class
- Kinase Inhibitor [EPC]; mTOR Inhibitor Immunosuppressant [EPC]
- Marketing Start
- 10/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is EVEROLIMUS used for?
EVEROLIMUS contains everolimus. It is a tablet taken oral. Consult your doctor for specific uses.
Is EVEROLIMUS a controlled substance?
EVEROLIMUS is not classified as a controlled substance by the DEA.
What is the generic name for EVEROLIMUS?
The generic name for EVEROLIMUS is everolimus. There are 10 other brand versions of everolimus.
What is the NDC code for EVEROLIMUS 2.5 mg/1?
The NDC (National Drug Code) for EVEROLIMUS 2.5 mg/1 is 72603-254, listed by NorthStar RxLLC.